HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
Adam
K
K
Department of Immunology, Hippokration Hospital of Thessaloniki, Aristotelian University of Thessaloniki, Greece.
Polymenidis
Z
Z
Papakyriazi
L
L
Alexopoulos
E
E
Parapanissiou
E
E
Antoniadis
A
A
Papadimitriou
M
M
D000293:Adolescent; D000328:Adult; D002102:Cadaver; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006115:Greece; D015234:HLA-A Antigens / Q000276:immunology*; D015235:HLA-B Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000276:immunology* / Q000401:mortality / Q000517:prevention & control; D015996:Survival Rate
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents